News

His mother’s long fight with sickle cell disease prompted rapper Keenan “Special” Bristol to pursue a project to raise awareness about a condition that claims thousands of lives annually.
Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
I signed up with Dish when I first built my house in Florida. From the beginning I was having issues with it. After 4 yrs I finally had enough. They had come out 5 times to replace the Joey ...